These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 34758903)

  • 1. Population SARS-CoV-2 Seroprevalence Using Antenatal Serum Samples in British Columbia, Canada.
    McClymont E; Elwood C; Sekirov I; Morshed M; Levett P; Liu A; Jassem A; Sbihi H; Ogilvie G; Krajden M; Money D
    J Obstet Gynaecol Can; 2021 Nov; 43(11):1242-1243. PubMed ID: 34758903
    [No Abstract]   [Full Text] [Related]  

  • 2. Canadian SARS-CoV-2 serological survey using antenatal serum samples: a retrospective seroprevalence study.
    Atkinson A; Albert A; McClymont E; Andrade J; Beach L; Bolotin S; Boucoiran I; Bullard J; Charlton C; Crane J; Dougan S; Forest JC; German GJ; Giguère Y; Girouard G; Hankins C; Krajden M; Lang A; Levett P; Minion J; Neudorf C; Poliquin V; Robinson JL; Scott H; Stein DR; Tran V; Zahariadis G; Zhou HY; Money D;
    CMAJ Open; 2023; 11(2):E305-E313. PubMed ID: 37015743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seropositivity of SARS-CoV-2 in an unvaccinated cohort in British Columbia, Canada: a cross-sectional survey with dried blood spot samples.
    Racey CS; Booth A; Albert A; Smith LW; Krajden M; Murray MCM; Côté HCF; Gottschlich A; Goldfarb DM; Sadarangani M; Galea LAM; Kaida A; Brotto LA; Ogilvie GS
    BMJ Open; 2022 Aug; 12(8):e062567. PubMed ID: 36038173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 cross-sectional seroprevalence study among public school staff in Metro Vancouver after the first Omicron wave in British Columbia, Canada.
    Watts AW; Mâsse LC; Goldfarb DM; Irvine MA; Hutchison SM; Muttucomaroe L; Poon B; Barakauskas VE; O'Reilly C; Bosman E; Reicherz F; Coombs D; Pitblado M; O'Brien SF; Lavoie PM
    BMJ Open; 2023 Jun; 13(6):e071228. PubMed ID: 37308276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 seroprevalence among Vancouver public school staff in British Columbia, Canada: a cross-sectional study.
    Goldfarb DM; Mâsse LC; Watts AW; Hutchison SM; Muttucomaroe L; Bosman ES; Barakauskas VE; Choi A; Dhillon N; Irvine MA; Reicherz F; O'Reilly C; Sediqi S; Xu RY; Razzaghian HR; Sadarangani M; Coombs D; O'Brien SF; Lavoie PM
    BMJ Open; 2022 Apr; 12(4):e057846. PubMed ID: 35383082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-Canada Variability in Blood Donor SARS-CoV-2 Seroprevalence by Social Determinants of Health.
    O'Brien SF; Caffrey N; Yi QL; Bolotin S; Janjua NZ; Binka M; Thanh CQ; Stein DR; Lang A; Colquhoun A; Pambrun C; Reedman CN; Drews SJ
    Microbiol Spectr; 2023 Feb; 11(1):e0335622. PubMed ID: 36625634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced surveillance of COVID-19 in Scotland: population-based seroprevalence surveillance for SARS-CoV-2 during the first wave of the epidemic.
    Dickson E; Palmateer NE; Murray J; Robertson C; Waugh C; Wallace LA; Mathie L; Heatlie K; Mavin S; Gousias P; Von Wissman B; Goldberg DJ; McAuley A
    Public Health; 2021 Jan; 190():132-134. PubMed ID: 33453689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence of SARS-CoV-2-specific IgG antibodies in Kashmir, India, 7 months after the first reported local COVID-19 case: results of a population-based seroprevalence survey from October to November 2020.
    Khan SMS; Qurieshi MA; Haq I; Majid S; Ahmad J; Ayub T; Bhat AA; Fazili AB; Ganai AM; Jan Y; Kaul RU; Khan ZA; Masoodi MA; Mushtaq B; Nazir F; Nazir M; Raja MW; Rasool M; Asma A; Ayoub S; Aziz M; Bhat AA; Chowdri IN; Ismail S; Kawoosa MF; Khan MA; Khan MS; Kousar R; Lone AA; Nabi S; Obaid M; Qazi TB; Sabah I; Sumji IA
    BMJ Open; 2021 Sep; 11(9):e053791. PubMed ID: 34556519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence of SARS-CoV-2 significantly varies with age: Preliminary results from a mass population screening.
    Pagani G; Conti F; Giacomelli A; Bernacchia D; Rondanin R; Prina A; Scolari V; Gandolfi CE; Castaldi S; Marano G; Ottomano C; Boracchi P; Biganzoli E; Galli M
    J Infect; 2020 Dec; 81(6):e10-e12. PubMed ID: 32961253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of COVID-19 and seroprevalence to SARS-CoV-2 in a rheumatologic patient population from a tertiary referral clinic in Israel.
    Eviatar T; Elalouf O; Furer V; Goldstein-Lahat Y; Paran Y; Pel S; Nevo S; Zisapel M; Alcalay Y; Elkayam O
    Intern Med J; 2021 May; 51(5):682-690. PubMed ID: 33844415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 seroprevalence in the Vatican City State.
    Ralli M; Arcangeli A; Soave PM; Voglino MC; De-Giorgio F
    Eur J Intern Med; 2021 Apr; 86():98-99. PubMed ID: 33581980
    [No Abstract]   [Full Text] [Related]  

  • 12. SARS-CoV-2 seroprevalence among blood donors after the first COVID-19 wave in Canada.
    Saeed S; Drews SJ; Pambrun C; Yi QL; Osmond L; O'Brien SF
    Transfusion; 2021 Mar; 61(3):862-872. PubMed ID: 33527398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of initial SARS-CoV-2 seroprevalence in the most affected districts in the municipality of São Paulo, Brazil.
    Tess BH; Granato CFH; Alves MCGP; Pintão MCT; Nunes MC; Rizzatti EG; Reinach FC
    Braz J Infect Dis; 2021; 25(4):101604. PubMed ID: 34416142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid Detection of SARS-CoV-2 Variants of Concern, Including B.1.1.28/P.1, British Columbia, Canada.
    Matic N; Lowe CF; Ritchie G; Stefanovic A; Lawson T; Jang W; Young M; Dong W; Brumme ZL; Brumme CJ; Leung V; Romney MG
    Emerg Infect Dis; 2021 Jun; 27(6):1673-1676. PubMed ID: 33784237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 Seroprevalence Survey Estimates Are Affected by Anti-Nucleocapsid Antibody Decline.
    Bolotin S; Tran V; Osman S; Brown KA; Buchan SA; Joh E; Deeks SL; Allen VG
    J Infect Dis; 2021 Apr; 223(8):1334-1338. PubMed ID: 33400794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 antibody seroprevalence in India, August-September, 2020: findings from the second nationwide household serosurvey.
    Murhekar MV; Bhatnagar T; Selvaraju S; Saravanakumar V; Thangaraj JWV; Shah N; Kumar MS; Rade K; Sabarinathan R; Asthana S; Balachandar R; Bangar SD; Bansal AK; Bhat J; Chopra V; Das D; Deb AK; Devi KR; Dwivedi GR; Khan SMS; Kumar CPG; Kumar MS; Laxmaiah A; Madhukar M; Mahapatra A; Mohanty SS; Rangaraju C; Turuk A; Baradwaj DK; Chahal AS; Debnath F; Haq I; Kalliath A; Kanungo S; Kshatri JS; Lakshmi GGJN; Mitra A; Nirmala AR; Prasad GV; Qurieshi MA; Sahay S; Sangwan RK; Sekar K; Shukla VK; Singh PK; Singh P; Singh R; Varma DS; Viramgami A; Panda S; Reddy DCS; Bhargava B;
    Lancet Glob Health; 2021 Mar; 9(3):e257-e266. PubMed ID: 33515512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of SARS-CoV-2 Delta Variant and Effect of Nonpharmaceutical Interventions, British Columbia, Canada.
    Chan YLE; Irvine MA; Prystajecky N; Sbihi H; Taylor M; Joffres Y; Schertzer A; Rose C; Dyson L; Hill EM; Tildesley M; Tyson JR; Hoang LMN; Galanis E
    Emerg Infect Dis; 2023 Oct; 29(10):1999-2007. PubMed ID: 37640374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence of SARS-CoV-2 Infection in Portugal in May-July 2020: Results of the First National Serological Survey (ISNCOVID-19).
    Kislaya I; Gonçalves P; Barreto M; Sousa R; Garcia AC; Matos R; Guiomar R; Rodrigues AP;
    Acta Med Port; 2021 Feb; 34(2):87-94. PubMed ID: 33641702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 IgG seroprevalence in healthcare workers and other staff at North Bristol NHS Trust: A sociodemographic analysis.
    Jones CR; Hamilton FW; Thompson A; Morris TT; Moran E
    J Infect; 2021 Mar; 82(3):e24-e27. PubMed ID: 33271169
    [No Abstract]   [Full Text] [Related]  

  • 20. SARS-COV-2 Infection and Specific Antibody Detection on Health Care Workers from a Military Hospital in Madrid, Spain.
    Simón Sacristán M; Ybarra de Villavicencio C; Collazos Blanco A; Mayo Montero ME; Ariñez Fernández MDC; Suárez Prieto A; Zamora Cintas MI; Mateo Maestre M
    Curr Microbiol; 2021 Aug; 78(8):2910-2915. PubMed ID: 34156544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.